Literature DB >> 6199030

Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus.

D A Isenberg, Y Shoenfeld, R S Schwartz.   

Abstract

Analysis of the binding of serum from 56 systemic lupus erythematosus patients to native DNA (nDNA), denatured DNA (dDNA), poly I, poly(dT), RNA, and cardiolipin revealed multiple antigen binding in many of the sera. Raised levels of antibodies (IgG and/or IgM) to denatured DNA were found in the highest percentage (68%) of patients. A small subset of patients with multiple raised IgM antibodies, renal disease, and vasculitic skin rash was identified. No correlation between multiple serologic activity and clinical disease was found.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199030     DOI: 10.1002/art.1780270203

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  30 in total

1.  Accuracy of semiquantitative immunoenzymatic methods in quantitation of anti-topoisomerase I (Scl-70) antibodies.

Authors:  D Villalta; N Bizzaro; S Platzgummer; A Antico; M Tampoia; L Camogliano; D Bassetti; M Pradella; A Piazza; F Manoni; R Tozzoli; E Tonutti
Journal:  Clin Rheumatol       Date:  2004-12-10       Impact factor: 2.980

2.  Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometry.

Authors:  V B Dhillon; M C Davies; M L Hall; J M Round; P J Ell; H S Jacobs; M L Snaith; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

3.  Sequential study of bone mineral density in patients with systemic lupus erythematosus.

Authors:  F Formiga; J M Nolla; I Moga; D Roig-Escofet
Journal:  Ann Rheum Dis       Date:  1996-11       Impact factor: 19.103

4.  Serum monoclonal antibodies derived from patients with multiple myeloma react with mycobacterial phosphoinositides and nuclear antigens.

Authors:  D Buskila; M Abu-Shakra; H Amital-Teplizki; A R Coates; M Krupp; S Sukenik; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

5.  Disease activity in systemic lupus erythematosus related to a range of antibodies binding DNA and synthetic polynucleotides.

Authors:  D A Isenberg; C Dudeney; W Williams; A Todd-Pokropek; B D Stollar
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

6.  Individual variation in the isotype profile of anti-histone autoantibodies in systemic lupus erythematosus.

Authors:  G Fellows; N Gittoes; D G Scott; J S Coppock; A Wainwright; M Goodall; B M Turner
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

7.  Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.

Authors:  G Senaldi; V A Makinde; D Vergani; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

8.  Anti-DNA antibodies of IgA class in patients with systemic lupus erythematosus.

Authors:  M Gripenberg; T Helve
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

9.  Assessment of lupus: where are we now?

Authors:  E Hay; C Gordon; P Emery
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

10.  A long-term immunological study of childhood onset systemic lupus erythematosus.

Authors:  C K Ting; K H Hsieh
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.